Unknown

Dataset Information

0

Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing.


ABSTRACT: Thiopurine methyltransferase (TPMT) activity exhibits monogenic co-dominant inheritance, with ethnic differences in the frequency of occurrence of variant alleles. With conventional thiopurine doses, homozygous TPMT-deficient patients (~1 in 178 to 1 in 3,736 individuals with two nonfunctional TPMT alleles) experience severe myelosuppression, 30-60% of individuals who are heterozygotes (~3-14% of the population) show moderate toxicity, and homozygous wild-type individuals (~86-97% of the population) show lower active thioguanine nucleolides and less myelosuppression. We provide dosing recommendations (updates at http://www.pharmgkb.org) for azathioprine, mercaptopurine (MP), and thioguanine based on TPMT genotype.

SUBMITTER: Relling MV 

PROVIDER: S-EPMC3098761 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC3831181 | biostudies-literature
| S-EPMC3748365 | biostudies-literature
| S-EPMC3374459 | biostudies-literature
| S-EPMC4481158 | biostudies-literature
| S-EPMC3564416 | biostudies-literature
| S-EPMC3994233 | biostudies-literature
| S-EPMC6576267 | biostudies-literature
| S-EPMC3187550 | biostudies-literature
| S-EPMC4675696 | biostudies-literature
| S-EPMC4206662 | biostudies-literature